Addgene: Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.

This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Browse
Martine Roussel
Murphy et al

Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.
Murphy BL, Obad S, Bihannic L, Ayrault O, Zindy F, Kauppinen S, Roussel MF
Cancer Res. 2013 Oct 21. PubMed Article

Plasmids from Article

ID	Plasmid	Purpose
49379	pmirGLO-Bmpr2-1719	Insert is a fragment of the Bmpr2 3'-UTR that contains miR-17 and miR-19 binding sites. To be used for 3'UTR assay.
49380	pmirGLO-Bmpr2-Δ17	Insert is a fragment of the Bmpr2 3'-UTR that contains a mutated miR-17 binding site. To be used for 3'UTR assay.
49381	pmirGLO-Bmpr2-Δ19	Insert is a fragment of the Bmpr2 3'-UTR that contains a mutated miR-19 binding site. To be used for 3'UTR assay.
49382	pmirGLO-Smad5-1719	Insert is a fragment of the Smad5 3'-UTR that contains miR-17 and miR-19 binding sites. To be used for 3'UTR assay.
49383	pmirGLO-Smad4-1719	Insert is a fragment of the Smad4 3'-UTR that contains miR-17 and miR-19 binding sites. To be used for 3'UTR assay.

Antibodies from Article